Angiotensin II activates NADPH oxidase in isolated rat hearts subjected to ischaemia-reperfusion

European Journal of Pharmacology

Volumn 462, Issue 1-3, 2003, Pages 145-154

  Oudot, Alexandra ^a   Vergely, Catherine ^a   Ecarnot Laubriet, Aline ^a   Rochette, Luc ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

Angiotensin AT1 receptor; Angiotensin II; Heart; Ischaemia reperfusion; Losartan; NADPH oxidase

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; LACTATE DEHYDROGENASE; LOSARTAN; MESSENGER RNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME RELEASE; HEART ARRHYTHMIA; HEART MUSCLE REPERFUSION; INCIDENCE; INOTROPISM; ISCHEMIA; MALE; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASOCONSTRICTION;

EID: 0037458688     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01315-3     Document Type: Article

References (43)

1. Assem M., Teyssier J., Benderitter M., Terrand J., Laubriet A., Javouhey A., David M., Rochette L. Pattern of superoxide dismutase enzymatic activity and RNA changes in rat heart ventricles after myocardial infarction. Am. J. Pathol. 151:1997;549-555.
2. Busche S., Gallinat S., Bohle R.M., Reinecke A., Seebeck J., Franke F., Fink L., Zhu M., Summers C., Unger T. Expression of angiotensin AT(1) and AT(2) receptors in adult rat cardiomyocytes after myocardial infarction. A single-cell reverse transcriptase-polymerase chain reaction study. Am. J. Pathol. 157:2000;605-611.
3. De Gasparo M., Catt K.J., Inagami T., Wright J.W., Unger T. International Union of Pharmacology: XXIII. The angiotensin II receptors. Pharmacol. Rev. 52:2000;415-472.
4. Ecarnot-Laubriet A., De Luca K., Vandroux D., Moisant M., Bernard C., Assem M., Rochette L., Teyssier J. Downregulation and nuclear relocation of MLP during the progression of right ventricular hypertrophy induced by chronic pressure overload. J. Mol. Cell. Cardiol. 32:2000;2385-2395.
5. 2 receptor antagonists on recovery of mechanical function after ischemia-reperfusion in isolated working rat hearts. Circulation. 94:1996;3087-3089.
6. Ford W.R., Clanachan A.S., Lopaschuk G.D., Schulz R., Jugdutt B.I. Intrinsic ANG II type 1 receptor stimulation contributes to recovery of postischemic mechanical function. Am. J. Physiol. 274:1998;H1524-H1531.
7. Ford W.R., Clanachan A.S., Hiley C.R., Jugdutt B.I. Angiotensin II reduces infarct size and has no effect on post-ischaemic contractile dysfunction in isolated rat hearts. Br. J. Pharmacol. 134:2001;38-45.
8. Fukui T., Ishizaka N., Rajagopalan S., Laursen J.B., Capers Q., Taylor W.R., Harrison D.G., De Leon H., Wilcox J.N., Griendling K.K. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ. Res. 80:1997;45-51.
9. Fukui T., Yoshiyama M., Hanatani A., Omura T., Yoshikawa J., Abe Y. Expression of p22-phox and gp91-phox, essential components of NADPH oxidase, increases after myocardial infarction. Biochem. Biophys. Res. Commun. 281:2001;1200-1206.
10. Griendling K.K., Minieri C.A., Ollerenshaw J.D., Alexander R.W. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 74:1994;1141-1148.
11. 1 receptor. TIPS. 17:1996;135-140.
12. Iliou J., Villeneuve N., Fournet-Bourguignon M., Robin F., Jacquemin C., Lestriez V., Petit C., Pillon A., Pillon J.P., Pillon V. Mathematical treatment of chemiluminescence data allowing an optimised kinetic analysis of vascular NAD(P)H-dependent superoxide anion production. Analusis. 28:2000;479-486.
13. Ishihata A., Endoh M. Species-related differences in inotropic effects of angiotensin II in mammalian ventricular muscle: receptors, subtypes and phosphoinositide hydrolysis. Br. J. Pharmacol. 114:1995;447-453.
14. 1 receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation. Mol. Pharmacol. 48:1995;601-609.
15. Leri A., Liu Y., Li B., Fiodaliso F., Malhotra A., Latini R., Kajstura J., Anversa P. Up-regulation of AT(1) and AT(2) receptors in postinfarcted hypertrophied myocytes and stretch-mediated apoptotic cell death. Am. J. Pathol. 156:2000;1663-1672.
16. Li C., Jackson R.M. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am. J. Physiol., Cell Physiol. 282:2002;C227-C241.
17. Lowry O., Rosenbrough N., Fair A., Randall R. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;268-273.
18. McPhail L.C., Waite K.A., Regier D.S., Nixon J.B., Qualliotine-Mann D., Zhang W.X., Wallin R., Sergeant S. A novel protein kinase target for the lipid second messenger phosphatidic acid. Biochim. Biophys. Acta. 1439:1999;277-290.
19. Mohazzab-H K.M., Kaminski P.M., Wolin M.S. Lactate and PO2 modulate superoxide anion production in bovine cardiac myocytes: potential role of NADH oxidase. Circulation. 96:1997;614-620.
20. Mollnau H., Wendt M., Szocs K., Lassegue B., Schulz E., Oelze M., Li H., Bodenschatz M., August M., Kleschyov A.L., Tsilimingas N., Walter U., Forstermann U., Meinertz T., Griendling K., Munzel T. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ. Res. 90:2002;E58-E65.
21. Moraru I., Popescu L.M., Maulik N., Liu X., Das D.K. Phospholipase D signaling in ischemic heart. Biochim. Biophys. Acta. 1139:1992;148-154.
22. Moravec C.S., Schluchter M.D., Paranandi L., Czerska B., Stewart R.W., Rosenkranz E., Bond M. Inotropic effects of angiotensin II on human cardiac muscle in vitro. Circulation. 82:1990;1973-1984.
23. Nio Y., Matsubara H., Murasawa S., Kanasaki M., Inada M. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J. Clin. Invest. 95:1995;46-54.
24. Noda K., Sasaguri M., Ideishi M., Ikeda M., Arakawa K. Role of locally formed angiotensin II and bradykinin in the reduction of myocardial infarct size in dogs. Cardiovasc. Res. 27:1993;334-340.
25. Rajagopalan S., Kurz S., Munzel T., Tarpey M., Freeman B.A., Griendling K.K., Harrison D.G. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest. 97:1996;1916-1923.
26. Sakurai K., Norota I., Tanaka H., Kubota I., Tomoike H., Endoh M. Negative inotropic effects of angiotensin II, endothelin-1 and phenylephrine in indo-1 loaded adult mouse ventricular myocytes. Life Sci. 70:2002;1173-1184.
27. Sekine T., Kusano H., Nishimaru K., Tanaka Y., Tanaka H., Shigenobu K. Developmental conversion of inotropism by endothelin I and angiotensin II from positive to negative in mice. Eur. J. Pharmacol. 374:1999;411-415.
28. Sohn H.Y., Raff U., Hoffmann A., Gloe T., Heermeier K., Galle J., Pohl U. Differential role of angiotensin II receptor subtypes on endothelial superoxide formation. Br. J. Pharmacol. 131:2000;667-672.
29. Sorescu D., Somers M.J., Lassegue B., Grant S., Harrison D.G., Griendling K.K. Electron spin resonance characterization of the NAD(P)H oxidase in vascular smooth muscle cells. Free Radic. Biol. Med. 30:2001;603-612.
30. Souren J.E., Van Der Mast C., Van Wijk R. NADPH-oxidase-dependent superoxide production by myocyte-derived H9c2 cells: influence of ischemia, heat shock, cycloheximide and cytochalasin D. J. Mol. Cell. Cardiol. 29:1997;2803-2812.
31. Sun Y., Weber K.T. Angiotensin II receptor binding following myocardial infarction in the rat. Cardiovasc. Res. 28:1994;1623-1628.
32. Thomas G.P., Ferrier G.R., Howlett S.E. Losartan exerts antiarrhythmic activity independent of angiotensin II receptor blockade in simulated ventricular ischemia and reperfusion. J. Pharmacol. Exp. Ther. 278:1996;1090-1097.
33. Touyz R.M., Schiffrin E.L. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol. Rev. 52:2000;639-672.
34. Traquandi C., Riva E. Cardiac effects of angiotensin I and angiotensin II: dose-response studies in the isolated perfused rat heart. Pharmacol. Res. 37:1998;57-65.
35. Van der Vusse G.J., Reneman R.S., Van Bilsen M. Accumulation of arachidonic acid in ischemic/reperfused cardiac tissue: possible causes and consequences. Prostaglandins, Leukot. Essent. Fat. Acids. 57:1997;85-93.
36. Vergely C., Tabard A., Maupoil V., Rochette L. Isolated perfused rat hearts release secondary free radicals during ischemia reperfusion injury: cardiovascular effects of the spin trap alpha-phenyl N-tert-butylnitrone. Free Radic. Res. 35:2001;475-489.
37. Vergely C., Perrin C., Laubriet A., Oudot A., Zeller M., Guilland J.C., Rochette L. Postischemic myocardial recovery and oxidative stress status of vitamin C deficient rat hearts. Cardiovasc. Res. 51:2001;89-99.
38. Walker M.J., Curtis M.J., Hearse D.J., Campbell R.W., Janse M.J., Yellon D.M., Cobbe S.M., Coker S.J., Harness J.B., Harron D.W.et al. The Lambeth conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc. Res. 22:1988;447-455.
39. 1 receptor antagonist candesartan and the surmountable antagonist losartan on ischemia/reperfusion injury in rat hearts. Eur. J. Pharmacol. 380:1999;13-21.
40. Wroblewski F., La Due J. Lactic dehydrogenase activity in blood. Proc. Expl. Biol. Med. 90:1955;1211-1224.
41. Yang B.C., Phillips M.I., Ambuehl P.E., Shen L.P., Mehta P., Mehta J.L. Increase in angiotensin II type 1 receptor expression immediately after ischemia-reperfusion in isolated rat hearts. Circulation. 96:1997;922-926.
42. Zafari A.M., Ushio-Fukai M., Minieri C.A., Akers M., Lassegue B., Griendling K.K. Arachidonic acid metabolites mediate angiotensin II-induced NADH/NADPH oxidase activity and hypertrophy in vascular smooth muscle cells. Antioxid. Redox Signal. 1:1999;167-179.
43. Zhang H., Schumeisser A., Garlichs C.D., Plotze K., Damme U., Mugge A., Daniel W.G. Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH-/NADPH-oxidases. Cardiovasc. Res. 44:1999;215-222.